See more : Annaly Capital Management, Inc. (NLY-PF) Income Statement Analysis – Financial Results
Complete financial analysis of Natural Biocon (India) Limited (NATURAL.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Natural Biocon (India) Limited, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- iWallet Corporation (IWAL) Income Statement Analysis – Financial Results
- Novateor Research Laboratories (NOVATEOR.BO) Income Statement Analysis – Financial Results
- PT Dua Putra Utama Makmur Tbk (DPUM.JK) Income Statement Analysis – Financial Results
- Labat Africa Limited (LAB.JO) Income Statement Analysis – Financial Results
- ASX Limited (ASXFY) Income Statement Analysis – Financial Results
Natural Biocon (India) Limited (NATURAL.BO)
About Natural Biocon (India) Limited
Natural Biocon India Ltd. engages in the provision of agricultural produce. It offers chemical and natural extracts. Its products include nicotine, caffeine, tenin, morphine, codeine, strychnine, nuxvomicase, brucine, barely malt, maltose, malt sugar, and all its derivatives. The company was founded on August 27, 1992 and is headquartered in Ahmedabad, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 135.34M | 12.54M | 4.82M | 1.32M | 0.00 | 4.49M | 10.43M | 1.54M |
| Cost of Revenue | 128.45M | 9.24M | 3.10M | 1.01M | 0.00 | 417.22K | 87.40K | 383.27K |
| Gross Profit | 6.88M | 3.30M | 1.71M | 311.43K | 0.00 | 4.07M | 10.34M | 1.15M |
| Gross Profit Ratio | 5.09% | 26.32% | 35.56% | 23.61% | 0.00% | 90.71% | 99.16% | 75.04% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 4.63M | 819.00K | 826.21K | 268.80K | 315.96K | 2.95M | 334.09K | 66.99K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 4.63M | 819.00K | 826.21K | 268.80K | 315.96K | 2.95M | 334.09K | 66.99K |
| Cost & Expenses | 133.08M | 10.06M | 3.93M | 1.28M | 315.96K | 3.37M | 421.49K | 450.26K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 95.84K | 0.00 | 0.00 |
| Interest Expense | 0.00 | 12.00K | 8.62K | 5.97K | 819.00 | 6.31K | 0.00 | 0.00 |
| Depreciation & Amortization | 167.90K | 228.49K | 236.56K | 206.30K | 171.86K | 161.14K | 52.52K | 22.82K |
| EBITDA | 2.25M | 2.48M | 887.31K | 42.63K | -315.96K | 1.22M | 10.01M | 1.09M |
| EBITDA Ratio | 1.66% | 19.79% | 18.41% | 3.23% | 0.00% | 24.95% | 95.96% | 70.68% |
| Operating Income | 2.25M | 2.48M | 887.31K | 42.63K | -315.96K | 1.12M | 10.01M | 1.09M |
| Operating Income Ratio | 1.66% | 19.79% | 18.41% | 3.23% | 0.00% | 24.95% | 95.96% | 70.68% |
| Total Other Income/Expenses | 0.00 | -12.00K | -8.62K | -5.97K | -814.00 | 89.53K | -1.00 | 0.00 |
| Income Before Tax | 2.25M | 2.47M | 878.69K | 36.66K | -316.77K | 1.21M | 10.01M | 1.09M |
| Income Before Tax Ratio | 1.66% | 19.69% | 18.24% | 2.78% | 0.00% | 26.95% | 95.96% | 70.68% |
| Income Tax Expense | 726.42K | 679.00K | 219.67K | 9.17K | 483.69K | 483.69K | 3.00M | 325.62K |
| Net Income | 1.53M | 1.79M | 659.01K | 27.50K | -800.47K | 726.06K | 7.01M | 759.79K |
| Net Income Ratio | 1.13% | 14.28% | 13.68% | 2.08% | 0.00% | 16.17% | 67.19% | 49.48% |
| EPS | 0.13 | 0.16 | 0.06 | 0.00 | -0.07 | 0.06 | 0.62 | 0.07 |
| EPS Diluted | 0.13 | 0.16 | 0.06 | 0.00 | -0.07 | 0.06 | 0.62 | 0.07 |
| Weighted Avg Shares Out | 11.37M | 11.37M | 11.37M | 11.37M | 11.37M | 11.37M | 11.37M | 11.37M |
| Weighted Avg Shares Out (Dil) | 11.37M | 11.37M | 11.37M | 11.37M | 11.37M | 11.37M | 11.37M | 11.37M |
Source: https://incomestatements.info
Category: Stock Reports